Type Public (SASE: BSNLR) Founded 1951 | Industry Pharmaceutical | |
 | ||
Key people Edin Arslanagić (Chief Executive Officer) Products Solid oral form medicines, ampule medicines, galenic products, non-pharmaceutical chemical products Revenue 88,056 million BAM (2007) Net income 7,796 million BAM (2007) Headquarters Sarajevo, Bosnia and Herzegovina | ||
Bosnalijek is the largest pharmaceutical company in Bosnia and Herzegovina. The organisation was established in 1951 and employs ~620 workers, out of which more than 50% have university level or higher qualifications. Its product portfolio consists of ~180 products. The company continues investment into R&D. Bosnalijek has established collaboration with several world-leading companies from the industry.
Bosnalijek is present in 22 countries worldwide: all neighbouring southeastern European countries, most eastern European countries, Libya and many French-speaking African countries, several countries from the Arabian peninsula and Caucasus, etc.
In 2005, International Finance Corporation provided Bosnalijek with a €7.5 million loan for the construction of an €18.5 million production and distribution center.